Endo S, Terazawa T, Goto M, Tanaka R, et al. Neoadjuvant docetaxel, oxaliplatin and S-1 therapy for the patients with large type 3 or type 4 gastric cancer (OGSG1902): protocol of a multi-center, phase II study. BMC Cancer 2022;22:811.
PMID: 35870893